[Trials with dolo-adamon in orthopedic diseases].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000983:Antipyrine / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy; D001892:Camphanes / Q000627:therapeutic use; D002422:Causalgia / Q000188:drug therapy; D002934:Cinnamates / Q000627:therapeutic use*; D003061:Codeine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D008744:Methylamines / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010019:Osteomyelitis / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D013125:Spinal Neoplasms / Q000188:drug therapy; D013451:Sulfonic Acids / Q000627:therapeutic use; D014103:Torticollis / Q000188:drug therapy
D000700:Analgesics; D001463:Barbiturates; D001892:Camphanes; D002934:Cinnamates; D006993:Hypnotics and Sedatives; D008744:Methylamines; D010276:Parasympatholytics; D013451:Sulfonic Acids; D000983:Antipyrine; D003061:Codeine
Erfahrungen mit Dolo-Adamon bei orthopädischen Erkrankungen.